Does vitamin D deficiency predict tumour malignancy in patients with bone tumours? Data from a multi-center cohort analysis
Open Access
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Journal of Bone Oncology
- Vol. 25, 100329
Abstract
No abstract availableKeywords
Funding Information
- Julius-Maximilians-Universität Würzburg
This publication has 53 references indexed in Scilit:
- Expression of the Chemokine Receptor CXCR7 in CXCR4-Expressing Human 143B Osteosarcoma Cells Enhances Lung Metastasis of Intratibial Xenografts in SCID MicePLOS ONE, 2013
- Clinicopathologic correlation of vitamin D receptor expression with retinoid X receptor and MIB-1 expression in primary and metastatic osteosarcomaAnnals of Diagnostic Pathology, 2012
- 1,25-Dihydroxyvitamin D3 Treatment Delays Cellular Aging in Human Mesenchymal Stem Cells while Maintaining Their Multipotent CapacityPLOS ONE, 2012
- Effect of 25‐hydroxyvitamin D3 and 1 α,25 dihydroxyvitamin D3 on differentiation and apoptosis of human osteosarcoma cell linesJournal of Orthopaedic Research, 2011
- The estimated benefits of vitamin D for GermanyMolecular Nutrition & Food Research, 2010
- Impact of vitamin D deficiency on the clinical presentation and prognosis of patients with newly diagnosed multiple myelomaAmerican Journal of Hematology, 2009
- 1α,25-Dihydroxyvitamin D3 Reduces c-Myc Expression, Inhibiting Proliferation and Causing G1 Accumulation in C4-2 Prostate Cancer CellsEndocrinology, 2009
- 25-Hydroxyvitamin D3 is a natural chemopreventive agent against carcinogen induced precancerous lesions in mouse mammary gland organ cultureBreast Cancer Research and Treatment, 2008
- Vitamin D DeficiencyNew England Journal of Medicine, 2007
- Predictive Value of Bone Resorption and Formation Markers in Cancer Patients With Bone Metastases Receiving the Bisphosphonate Zoledronic AcidJournal of Clinical Oncology, 2005